Pioneering research on Alzheimer’s disease prevention

The Barcelonaβeta Brain Research Center (BBRC) is the research institute of the Pasqual Maragall Foundation. It is devoted to the prevention of Alzheimer's disease and the study of cognitive functions affected in healthy and pathological aging.

ABOUT BBRC

Highlights

ANNUAL REPORT 2022

Discover the most outstanding information on the scientific, social and economic activity of the BBRC and the Pasqual Maragall Foundation in 2022.

HRS4R

BBRC is awarded with the Human Resources Excellence in Research, granted by the European Commission.

PUBLICATIONS

Check out the scientific production of BBRC program on Alzheimer’s Prevention.

Research Heroes

“Every time I enter this center, I have the feeling that I will take part in the solution for Alzheimer’s”

ENCARNA Research participant of the Alfa Study

“It is my duty do whatever I can for the research against Alzheimer’s. I will not probably benefit from the solution, but maybe my grandchildren will”.

JUAN PEDRO Research participant of the Alfa Study

LATEST NEWS

The results of the study indicate that preventive nutritional interventions could help improve brain function and prevent Alzheimer's-associated dementia

11 Jul | 2024

A diet rich in omega-3 fats may be key to preventing Alzheimer's

The research, based on data from 320 participants of the Alfa cohort, promoted by the ”la Caixa” Foundation, concludes that nutritional interventions could prevent the disease.

Donanemab joins the approval a year ago in the United States of another drug that also slowed down the cognitive deterioration caused by the disease, lecanemab

04 Jul | 2024

A new drug approved in the United States to treat the initial stages of Alzheimer's

The FDA has given the green light to donanemab, a monoclonal antibody that attacks amyloid protein plaques.

Latest Tweets

Tweets by fpmaragall

NEUROIMAGING PLATFORM

Customized integral service for research projects with cerebral magnetic resonance imaging

MORE INFORMATION